INTRODUCTION
Bacterial infections of the CNS are not usually subtle. Depending on the organism, illness can be fulminant and rapidly lethal (Neisseria meningitidis) or subacutely progressive, debilitating, and lethal (Mycobacterium tuberculosis). More indolent CNS infections, such as with Treponema pallidum, tend to have effects less deadly but no less substantial. The neurobehavioral effects of neurosyphilis are thought to have had significant effects on world history as numerous famous figures succumbed to general paresis of the insane. In this context it should not be surprising that the observation that Borrelia burgdorferi, the organism responsible for Lyme disease, can infect the CNS has led to substantial patient fear, physician anxiety, and Internet misinformation.
While neuroborreliosis has frequently been likened to neurosyphilis, perhaps the most significant similarity is that limitations of medical knowledge at the time of both diseases' initial recognition resulted in misattribution of all manner of unrelated clinical syndromes to these infections. Although the technology to diagnose Lyme disease has improved rapidly, many of the initial concerns and misunderstandings have persisted long after diagnostic issues were largely resolved, leading to a persistent mythology that has proven very difficult to debunk.
In fact, much is currently known about this infection. Its neurologic manifestations are quite well defined and generally easily treated; the infection is usually straightforward to diagnose and cure. The goal of this article is to provide a framework for understanding what does and does not constitute nervous system Lyme disease; how most appropriately to diagnose it; and, most importantly, how to treat it effectively.
BACKGROUND
The disease we refer to as Lyme disease is a multisystem infection caused by the tick-transmitted spirochete, B. burgdorferi. The most common manifestation of this infection is the almost unique rash known as erythema migrans, first described more than a century ago, 1 70 years before the responsible microorganism was identified. Over those 7 decades the disease was described syndromically, a historical precedent that now needs to be discarded.
As with many infections, the disseminating microorganism has specific organotropisms. In Europe, the first form of extracutaneous involvement described was neurologic. In 1922, Garin and Bujadoux 2 reported a patient with meningitis and painful polyradiculitis following a tick bite. In the United States, the earliest observations focused on rheumatologic involvement. 3 Characterization of Lyme arthritis led to a series of landmark studies culminating in the isolation of B. burgdorferi in 1982, 4 followed shortly thereafter by the demonstration that this organism was indeed the cause of this disease. 5, 6 At the same time, it became clear that Lyme arthritis was actually part of a multisystem disorder, usually associated with a prior erythema migrans, with occasional patients developing cardiac conduction abnormalities and a larger percentage developing the syndrome described years earlier by Garin and Bujadoux. 7 To complete the picture, in 1984, European investigators were able to identify the closely related microorganisms, 8 ultimately characterized as Borrelia garinii and Borrelia afzelii (and occasionally B. burgdorferi), responsible for the related disorders they had been treating with antibiotics for decades.
DIAGNOSIS
Normally the identification of a microorganism as the cause of an illness would be expected to simplify its diagnosis, allowing for greater clarity regarding the true spectrum of the disease and for better-informed treatment. However, this step was not as simple as one might have hoped. First, direct isolation of spirochetes from infected patients proved challenging, as it is difficult to grow B. burgdorferi in cultureVnot impossible, as in syphilis, but problematic. Culture requires special media, with incubation at lower temperatures and for a substantially longer period of time than for other organisms, conditions not easily provided in most diagnostic microbiology laboratories. Even PCR-based technologies have proven to be of low diagnostic sensitivity, probably because the organism is present primarily in tissue, with very few spirochetes in accessible fluids such as blood or CSF. As a result, diagnosis remains dependent primarily on demonstration of the serologic response to the organism.
Serologic testing for diagnosing any infection has at least three inherent limitations. (1) When the host immune system is first exposed to a microorganism, it takes time before the antibody response develops to the point where antibody concentrations are discernible above background nonspecific reactivity. Thus, in patients in the first 4 weeks or so of Lyme disease, such as in many patients with erythema migrans and even some with cranial neuropathies, serologic test results are often negative. h When the host immune system is first exposed to a microorganism, it takes time before the antibody response develops to the point where antibody concentrations are discernible above background nonspecific reactivity.
While this is a false negative in the strictest sense, it is also a normal biologic phenomenon seen in all infections and does not invalidate the use of serologic tests in other, more appropriate contexts. In patients who have been ill for 4 weeks or longer, serologies should be positive in most instances ( Table 5- (2) By design (teleologically speaking), once the host's immune response has started to produce antibodies, it will typically continue to do so for an extended period of time. This poses two challenges. Since antibodies do not disappear the instant an infection is cured, serologic testing cannot be used as an indication of treatment efficacy or as a rationale for continued treatment. Equally importantly, since antibodies can be present years or decades 9 after successful elimination of an infection, it is always important to consider whether a positive serology relates to a current active infection or an irrelevant exposure in the remote past. Excluding patients in the first 4 weeks or so of infection, currently recommended two-tier serologic testing has high sensitivity, specificity, and predictive value (Table 5-1). The recommended procedure 10 begins with a sensitive but less specific screening test, typically an ELISA for antiYB. burgdorferi antibodies. Sera that are positive or borderline are then tested by Western blot to identify the specific antigens to which antibodies react. Criteria for interpreting IgM and IgG blots were developed based on a statistical analysis of patterns in large numbers of patients with and without B. burgdorferi infection.
KEY POINTS

11
Some bands that are known to be highly specific for B. burgdorferi were not included, because these antibodies occur so infrequently as to have little predictive value. None of the bands used were selected for their uniqueness, but rather because in various combinations, they provide excellent diagnostic specificity and positive and negative predictive values. IgG blots are interpreted as positive when five of 10 selected bands are present (Table 5-1). IgM blots are interpreted as positive when two of three selected bands are present. Because only two IgM bands are required, and because IgM has far more nonspecific binding than IgG, great caution is required in interpreting IgM blots. They should only be used in patients in whom symptoms are of a month's duration or less. Beyond this time patients should have developed an IgG response, and IgG blots will be far more specific. In patients with only IgM positivity but symptoms lasting 1 month or longer, or with a negative ELISA result but positive blot, the Western blot findings are almost always spurious. 12 Serologies do not become temporarily negative while a patient receives antibiotics. Early concerns that partial incomplete treatment might render a patient seronegative 13 despite ongoing infection have not been supported by subsequent studies. In brief, while false negatives are common in the first month or so of infection, they are not established to occur in patients with infection of longer duration.
Analogous techniques can be used to diagnose CNS infection. The CNS behaves as an independent immune compartment. Infection leads to in-migration and proliferation of B cells specific to the invading organism and, hence, h While false negatives are common in the first month or so of infection, they are not established to occur in patients with infection of longer duration.
intrathecal production of the antibody targeted against B. burgdorferi. This in-migration appears to be driven by early elevations in the CSF concentration of CXCL13, 14 a B-cellYattracting chemokine; some have suggested that measurement of this can be diagnostically useful.
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A small amount of peripheral blood immunoglobulin (approximately 0.5% to 1.0%) normally filters into CSF. As a result, if a patient has circulating antiYB. burgdorferi antibodies in serum, they will be detectable in CSF. Similarly, if there is blood-brain barrier breakdown with a higher concentration of CSF immunoglobulin than normally expected, this too will lead to the detection of more B. burgdorferiYadhering antibody in the CSF than expected (reflecting higher nonspecific cross-reactivity). Consequently, assessment of intrathecal antibody production requires comparison of CSF and serum concentrations of specific antibodies, correcting for total immunoglobulin concentration in both compartments. 16 This can be done by a capture assay, by immunoglobulin measurement in serum and CSF with appropriate dilution of both, or by mathematic correction. Simultaneous measurement of serum and CSF concentrations is essential, however. Only when the relative concentration of specific antibody in the CSF exceeds that in serum (CSF to serum index greater than 1.0) can this be considered evidence of CNS infection.
Measurement of the amount of intrathecally produced antibody that is specific to B. burgdorferi can be useful in the diagnosis of CNS infection. In patients with only peripheral nervous system involvement, or with no neurologic involvement at all, there is no reason to expect CSF antibody to be present. Importantly, just as in peripheral blood, apparent CSF antibody excess can persist years after cure of a CNS infection. 9 Fortunately (from a diagnostic perspective), active CNS infection is usually marked by a CSF pleocytosis or increased protein concentration, changes that should improve following successful antimicrobial therapy.
The other principal shortcoming of this measurement as a diagnostic technique is that its sensitivity is undefined, ranging from 50% to 95% in various studies of differing populations.
17Y19
The potential for cross-reactions in other infections also exists, but only neurosyphilis results in significant CSF antibody cross-reactivity (relapsing fevers do not typically infect the CNS), and this can usually be differentiated with a nonspecific reaginic test such as the CSF rapid plasma reagin; results of these are rarely, if ever, positive in neuroborreliosis.
CLINICAL MANIFESTATIONS
Historically, the first described manifestations of the infection we now know as Lyme disease were dermatologic. In particular, erythema migrans, also known as erythema chronicum migrans, was first described in Europe in 1910 and in the United States in 1970. 20 A virtually pathognomonic rash beginning at the site of a hard-shelled Ixodes tick bite, erythema migrans consists of a slowly expanding erythroderma that enlarges over days to weeks, often reaching many inches in diameter. Spirochetes initially proliferate at the site of the tick bite. When sufficiently numerous, they slowly migrate centrifugally from the site of inoculation, typically for up to 30 days after the bite. Depending on the location on the body, the rash may be round or elliptical. Central pallor may be present, often but not invariably giving rise to a targetoid appearance. Hallmarks include its slow, steady enlargement and relatively asymptomatic nature. It usually is easily differentiated from an acute allergic reaction to the tick bite, which also is red and expands, but which typically occurs within hours of the bite, is intensely pruritic, and subsides spontaneously within a few days.
In some patients the rash becomes multifocal, with each new focus representing a nidus of spirochetes that spread hematogenously from the initial site, and the spirochetes then migrating centrifugally from this new focus. Not surprisingly, this bacterial dissemination is accompanied by the usual host inflammatory reaction to a bacteremia: fever, diffuse aches and pains, headaches, malaise, fatigue, etc. While this is often referred to as flulike, it is important to note that Lyme disease does not cause upper respiratory or gastrointestinal symptoms.
The differential diagnosis is limited. Fixed drug eruptions can appear similarly targetoid but do not evolve. Southern tickYassociated rash illness has been described in recent years in Missouri and surrounding states. 21 The etiology remains undetermined, but it clearly is not associated with a borrelial or other identified infection and has not been associated with extracutaneous manifestations.
In addition to erythema migrans, European dermatologists recognize two manifestations reported rarely in the United States. Borrelia lymphocytoma consists of an erythematous swelling, typically affecting the earlobe or the areola of the breast, and occurs relatively early in disseminated infection. Acrodermatitis atrophicans, a late manifestation, consists of tissue paperY like thinning and discoloration of the skin of one or more limbs. When Garin and Bujadoux described the first form of extracutaneous involvement, consisting of lymphocytic meningitis and painful polyradiculitis, they conjectured that it was caused by a tick-transmitted spirochetal infection, because of faintly positive Wasserman test results in their patients. 2 By the 1950s, it was widely recognized that the syndrome improved following penicillin treatment. 22 This disorder, known as Garin-Bujadoux-Bannwarth syndrome, is now considered to include all or part of a classic triad: lymphocytic meningitis, cranial neuritis, and polyradiculitis.
In the United States, the first extracutaneous manifestations described were rheumatologic. 3 It was the identification of a surprising number of children in Lyme and Old Lyme, Connecticut, diagnosed with juvenile rheumatoid arthritis that led directly to the identification of B. burgdorferi. As the affected population was studied further, additional extracutaneous disorders became apparent. Up to 5% of infected individuals developed otherwise unexplained heart block, on occasion requiring a temporary pacemaker. Ultimately a pattern of neurologic manifestations very similar to that described in Europe decades earlier became apparent.
NEUROLOGIC MANIFESTATIONS
One of the many oddities in the medical literature about this infection is the repeated emphasis on the differences between European and North American Lyme disease, which are attributed to different organotropisms or immunogenic features of the organisms prevalent in the two regions. Yet from neurologists' perspectives, the similarities are striking. In both regions, the nervous system is affected in 10% to 15% of patients, primarily in the first few months after the initial infection, during what is often termed acute disseminated infection (analogous to the second stage of syphilis aseptic meningitis and is similarly benign in nature. Algorithms have been proposed to differentiate it from enteroviral and other viral causes of meningitis. 23 Viral meningitis tends to have a more abrupt onset; Lyme meningitis is much more likely if a concomitant cranial neuropathy is present. CSF findings are similar, with a modest elevation of protein concentration (typically less than 150 mg/dL) and lymphocytic pleocytosis (typically less than 200 cells/2L) and normal glucose concentration. Lymphocytes often have a strong B-cell predominance. In patients with CNS inflammation of longer duration, particularly those infected with European strains, this persistent B-cell stimulation is reflected in the presence of oligoclonal bands and increased overall immunoglobulin production, as reflected in elevated IgG index or IgG synthesis rates. 19 Although lymphocytic meningitis often occurs in patients with Lyme radiculitis or cranial neuritis, it appears this association is neither necessary nor sufficient. Cranial and peripheral nerve involvement can occur anywhere along the course of affected nerves, not preferentially in the subarachnoid space. 24 Approximately three-fourths of patients with Lyme-associated cranial neuropathies present with a facial nerve palsy. Early studies suggested this could be bilateral in up to one-fourth of cases. 25 More recent data are lacking. In endemic areas in warm months, as many as one-fourth of facial nerve palsies may be associated with Lyme disease. 26 Since obviously this means three-fourths are not, a diagnosis of Lyme disease cannot be assumed in patients with facial nerve palsies. Outcomes are generally excellent. Antimicrobial treatment is recommended, primarily to prevent continued infection. Concomitant corticosteroid treatment does not appear to have an adverse effect on outcomes.
Other cranial nerves can be involved, with more rostral nerves appearing to be involved more frequently. Extraocular muscle palsies, trigeminal nerve symptoms, and hearing and balance issues occur infrequently compared to the seventh nerve. Only isolated case reports describe involvement of the vagus, glossopharyngeal, accessory, and hypoglossal nerves.
Probably the most frequently misdiagnosed entity is radiculoneuropathy. Patients present with acute dermatomal pain, largely indistinguishable from that of a mechanical radiculopathy, with similar weakness and reflex changes (Case 5-1 and Case 5-2). Hints in the history include the lack of a clear precipitant, but this is hardly unique. Findings often involve more than one dermatome, suggesting a less focal process. Ultimately the diagnosis requires thinking of it, eliminating a mechanical cause by imaging, and confirming the presence of B. burgdorferi infection serologically.
Neurophysiologic studies suggest that both cranial neuropathies and radiculoneuropathies are actually manifestations of a mononeuropathy multiplex. 24 In fact, this probably represents the underlying pathophysiology for virtually all peripheral nervous system Lyme disease, with described associated syndromes including typical mononeuropathies, brachial and lumbosacral plexopathies, and what appears to be a diffuse neuropathy but is actually a confluent mononeuropathy multiplex. Rare patients have been described with a Guillain-BarréYlike picture. 27 In at least one case series, neurophysiologic findings were convincing for demyelination. This has been so infrequent, however, that it is not obvious whether this is more than a chance co-occurrence.
Rare patients develop inflammation within the substance of the CNS. This 
Case 5-1
A 45-year-old man from a Lyme-endemic area presented with 5 months of intractable right upper-extremity pain described as burning in character and radiating down the neck and over the shoulder. Previous evaluation included MRI of the cervical spine demonstrating multilevel disc bulging without foraminal or central canal impingement. Extensive shoulder and chest imaging had been unrevealing. EMG showed primarily a C5 radiculopathy including paraspinous denervation, with additional changes in C6 innervated muscles. Three months of symptomatic management, including physical therapy, acupuncture, nonsteroidal anti-inflammatories, a trial of a methylprednisolone dose pack, and three cervical epidural steroid injections, provided no relief. On referral, his examination demonstrated mild weakness of deltoids, supraspinatus, and biceps, and depressed right biceps and brachioradialis jerks.
Lyme ELISA was strongly positive (4 times negative cutoff). Western blot demonstrated one of three IgM bands and eight of 10 IgG bands. CSF demonstrated 15 lymphocytes/2L, protein concentration of 85 mg/dL, normal glucose concentration, and CSF to serum Lyme antibody index of 2.0 (ie, CSF-specific antibody was proportionately twice that in serum after normalization for IgG concentration). The patient received 4 weeks of oral doxycycline, and symptoms resolved completely.
Comment. Lyme disease causes severe radicular-type pain in about 5% of patients. Although pain is typically dermatomal, careful evaluation often demonstrates somewhat more widespread involvement. Depending on location, pain can be misdiagnosed as visceral or mechanical radicular. Serologies are usually positive and CSF is often inflammatory. Symptoms are usually rapidly responsive to appropriate antibiotics.
Case 5-2
The identical twin brother of the patient in Case 5-1 presented with 5 months of identical symptoms, a negative Lyme ELISA, IgM Western blot with three of three bands, and IgG blot with one of 10 bands. CSF was normal except for a protein concentration of 85 mg/dL. His fasting blood glucose concentration was 195. Oral hypoglycemics were started, and his pain was treated symptomatically. No antibiotics were given. Symptoms subsided during the next 4 months.
Comment. Serologic test results should be invariably positive in a patient with neuroborreliosis that has been symptomatic for 5 months. With a negative ELISA, Western blots are of no value. In patients with disease of months' duration, a Western blot with solely IgM bands is undoubtedly a cross-reaction and not evidence of B. burgdorferi infection, past or present.
The entity referred to as Lyme encephalopathy, a manifestation often erroneously confused with encephalomyelitis, has caused more than its fair share of confusion among physicians and patients alike.
29Y31 Early in the evolution of our understanding about Lyme disease, it became apparent that many patients with active systemic inflammatory disease, arthritis in particular but other manifestations as well, described an accompanying sense of cognitive slowing and memory difficulty that interfered with day-to-day functioning (Case 5-3 and Case 5-4). Early studies showed that few of these patients had anything to suggest actual nervous system infection. Neurologic examinations and brain MRIs were generally normal, as were CSF examinations. Rather, this appeared to be analogous to the ''toxicmetabolic'' encephalopathy experienced by patients with innumerable other infections, such as pneumonia or urinary tract infections, or other active inflammatory disorders, such as rheumatoid arthritis, presumably mediated by cytokines or other molecules capable of crossing the blood-brain barrier and altering neurologic function without damaging the CNS. Unfortunately, the notion that this might reflect underlying brain damage became widespread, often supported by unreliable h Early studies showed that few patients with Lyme encephalopathy had anything to suggest actual nervous system infection. This appeared to be analogous to the ''toxic-metabolic'' encephalopathy experienced by patients with innumerable other infections, such as pneumonia or urinary tract infections, or other active inflammatory disorders such as rheumatoid arthritis.
Case 5-3
A 52-year-old man who frequently golfed in a Lyme-endemic area presented to a rheumatologist with a 1-year history of episodic, unprovoked, recurrent painful swelling of one knee or the other. On each occasion the knee became red, painful, and swollen; remained symptomatic for several weeks; and then subsided. He had been treated with nonsteroidal anti-inflammatories as well as steroid injections, none of which provided more than temporary relief. During this time, he reported, he had felt run down and cognitively slowed. When he argued in court as an attorney, he found his reasoning less rapid than before. He had no other neurologic complaints and recalled no erythema migrans or tick bites, although his high golf handicap frequently took him off the greens to pursue errant balls. His rheumatologist found an extremely elevated Lyme ELISA (6 times the upper limit) with nine bands on IgG Western blot. The patient had had a brain SPECT interpreted as showing multifocal hypoperfusion consistent with encephalitis; yet his brain MRI was normal. The patient was then referred to a neurologist for possible nervous system Lyme disease.
On neurologic examination, Mini-Mental State Examination and all other testing were normal. A lumbar puncture demonstrated normal CSF with a CSF to serum Lyme index of 0.5. The patient was treated with 4 weeks of oral doxycycline. During the next 5 months he noted that his arthritis subsided and his cognitive function returned to normal.
Comment. Patients with active systemic inflammatory disease (eg, urinary infections, pneumonia) often describe fatigue and problems with memory and mental focus. Presumably related to remote effects of cytokines, these are not evidence of brain disease and typically resolve as the broader illness resolves. Qualitative brain SPECT scans are used by some in this context. There is no evidence supporting the notion that the described abnormalities reflect brain disease, and the tests should probably not be performed.
tests such as qualitative brain SPECT scans, reinforcing patients' fears that Lyme disease causes an irreversible and debilitating neurologic disorder. In fact, the very rare instances of Lyme encephalomyelitis are usually easily differentiated from this encephalopathy; the latter patients need to be reassured that their symptoms are neither irreversible nor evidence of brain damage.
Much attention has focused on patients who have persisting fatigue and cognitive difficulty after being treated for Lyme disease with regimens that should be highly effective even in severe infections, a disorder often referred to as postYLyme syndrome. Data are unequivocal that repeated or longer courses of antibiotics do not cure these patients, 12 although the anti-inflammatory effects of some (eg, tetracyclines) or neuroactive effects of others (ceftriaxone having significant effects on glutamate neurotransmission) may cause transient, unsustained improvements in symptoms during treatment that disappear
Case 5-4
A cousin of the patient in Case 5-3 was a 55-year-old man who played tennis and had always lived in North Dakota. He had a 5-year history of intermittent right knee pain, somewhat improved after arthroscopic surgery, which found severe meniscus damage. During the year prior to his arthroscopic procedure, he described feeling run down and cognitively slowed. When he argued in court as an attorney, he found his reasoning was less rapid than before. He had no other neurologic complaints and recalled no erythema migrans or tick bites. His rheumatologist found a negative Lyme ELISA but three bands on his IgM Western blot and none on the IgG blot. He had not improved with 3 months of IV ceftriaxone, and his Lyme disease laboratory testing was unchanged. A brain SPECT scan was interpreted as showing multifocal hypoperfusion consistent with encephalitis; yet his brain MRI was normal. The patient was referred to a neurologist for possible nervous system Lyme disease.
On neurologic examination, Mini-Mental State Examination and all other testing were normal. A lumbar puncture demonstrated normal CSF. The patient was given reassurance that he had neither a CNS disease nor Lyme disease. The patient ultimately explained that he had always been a hyperachiever and his recent knee problems prevented him from enjoying his usual recreational activities and practicing law as vigorously as he would like. Physical therapy and a brief course of cognitive-behavioral therapy were arranged. Within 4 months he became more physically active and felt more like himself.
Comment. Patients with Lyme arthritis invariably have very high concentrations of antiYB. burgdorferi antibody in peripheral blood. The negative serology here effectively excludes the diagnosis. If that were not sufficient, he lived in an area where the potential for exposure to this infection is nonexistent. His knee symptoms differed from his cousin's in that, in this case, the same joint was always affected, and mechanical damage related to repeated athletic injuries was clearly present. His symptoms were nonspecific and in isolation would never warrant a diagnosis of Lyme disease or treatment with antibiotics. Isolated IgM bands on a Western blot with a negative ELISA, negative IgG blot, and long-standing symptoms are clearly artefactual. Findings on brain qualitative SPECT are again uninterpretable.
rapidly with discontinuation of treatment. This pattern is the opposite of that typically seen when treating an infection with antibiotics, in which systemic symptoms often improve modestly during treatment but then gradually improve more substantially over time as the inflammatory response to the infection gradually subsides.
Although some patients with postY Lyme syndrome meet criteria for a diagnosis of depression, this is by no means invariable and probably does not explain this state. Recent work suggests that some individuals are more at risk of this disorder following any of a number of stressors, including the physiologic and psychological stress of a significant illness. 32, 33 Although patients often consider the suggestion of a role for psychological factors as either dismissive or pejorative, it is nothing of the sort. It is only natural that anybody with a chronic illness, particularly somebody who is used to high levels of activity and achievement uninterrupted by distractions, will have a psychological response to this unwanted disruption. How people respond is a function of their underlying personality traits. Studies suggest that individuals with high negative and low positive affect are predisposed to these chronic persistent symptoms.
TREATMENT B. burgdorferi remains sensitive in vitro to many common antibiotics. Clinical studies have shown that oral doxycycline, ampicillin, and cefuroxime axetil are highly effective in most patients, including those with arthritis ( Table 5-2) . IV ceftriaxone, high-dose penicillin, and cefotaxime have been used in patients with severe disease, particularly nervous system infection, and in patients who have not responded to oral regimens. European studies have shown that oral doxycycline, which achieves spirochetocidal concentration in the CNS, is highly effective in Lyme meningitis, cranial neuritis, and radiculoneuritis. 19, 34 Although this has not been studied in the United States, the antibiotic sensitivities of the three prevalent Borrelia responsible for Lyme disease are sufficiently similar that there is no reason to doubt that this would be effective. Amoxicillin and cefuroxime axetil have not been tested in CNS disease, largely because of theoretic concerns about their poor CNS penetration of uninflamed meninges. However, the absence of a significant number of cases of Lyme meningitis among children initially treated with these two agents for disseminated but non-neurologic disease strongly suggests that these regimens eliminate any spirochetes that might have entered the CNS ( Table 5-2) .
CONCLUSIONS
Lyme disease affects the peripheral and central nervous systems in about 15% of patients. Other than a benign form of lymphocytic meningitis, CNS involvement rarely causes significant impairment. Cranial and peripheral nerves are involved more often and can be quite symptomatic. Antimicrobial therapy, even with oral doxycycline, is usually highly effective. h Oral doxycycline, which achieves spirochetocidal concentration in the CNS, is highly effective in Lyme meningitis, cranial neuritis, and radiculoneuritis.
